Chicago Equity Partners’s Usana Health Sciences USNA Stock Holding History

Chicago Equity Partners’s Portfolio USNA Stock Details USNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-3,255	Closed	-$256K	–	868
2019 Q4	$256K	Sell	3,255 -2,090	-39%	-$154K	0.01%	782
2019 Q3	$366K	Sell	5,345 -15	-0.3%	-$1.01K	0.02%	741
2019 Q2	$426K	Sell	5,360 -105	-2%	-$8.33K	0.02%	731
2019 Q1	$458K	Sell	5,465 -50	-0.9%	-$5.22K	0.02%	694
2018 Q4	$649K	Sell	5,515 -510	-8%	-$59K	0.03%	576
2018 Q3	$726K	Hold	6,025	–	–	0.02%	593
2018 Q2	$695K	Sell	6,025 -6,860	-53%	-$750K	0.02%	590
2018 Q1	$1.11M	Buy	12,885 +580	+5%	+$44.9K	0.04%	482
2017 Q4	$911K	Buy	+12,305	New	+$823K	0.03%	521

Other funds holding USNA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Chicago Equity Partners's USNA Position: Q1 2020 in Review

Chicago Equity Partners sold out of Usana Health Sciences (USNA) in Q1 2020, closing a stake of 3,255 shares — an estimated $256K sold.

Chicago Equity Partners first reported a position in USNA in Q4 2017 and held it in 9 quarters. The position peaked at $1.11M in Q1 2018. 169 funds tracked by Wall St. Rank hold USNA as of Q1 2020.

Chicago Equity Partners reported no remaining Usana Health Sciences position as of Q1 2020 after selling out during the quarter.
Chicago Equity Partners sold 3,255 Usana Health Sciences shares in Q1 2020, an estimated $256K.
Chicago Equity Partners first reported a position in Usana Health Sciences in Q4 2017 and held it in 9 quarters.
Chicago Equity Partners's Usana Health Sciences position peaked at $1.11M in Q1 2018.
169 funds tracked by Wall St. Rank held Usana Health Sciences as of Q1 2020.

Based on Chicago Equity Partners's 13F filing for Q1 2020, filed 6 May 2020.